<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-3d61-56a7-013e-6b81e6e455a5</uuid><title>Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients</title><shortTitle>Colon_Cancer</shortTitle><emeasureid>141</emeasureid><guid>8479f6d6-4200-4fd0-9438-30048ebe3e29</guid><version>3</version><status>Complete</status><nqfid extension="0385" root="2.16.840.1.113883.3.560.1"/><period uuid="5362abde-0f6d-459b-aa2c-3649d1936607"><startDate uuid="b8d77e05-7c25-43ff-b606-ba80b7a2cdc4">00000101</startDate><stopDate uuid="0256cc81-7c72-41d6-a8c7-378768b73f59">00001231</stopDate></period><steward id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</steward><developers><developer id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients aged 18 through 80 years with AJCC Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.</description><copyright>Copyright 2012 American Medical Association, American Society of Clinical Oncology, and National Comprehensive Cancer Network. All Rights Reserved.</copyright><disclaimer>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement (R) (PCPI[R]), American Society of Clinical Oncology, and National Comprehensive Cancer Network. These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI), American Society of Clinical Oncology, or National Comprehensive Cancer Network. Neither the AMA, American Society of Clinical Oncology, National Comprehensive Cancer Network, PCPI nor its members shall be responsible for any use of the Measures. 

THE MEASURES AND SPECIFICATIONS ARE PROVIDED ?AS IS? WITHOUT WARRANTY OF ANY KIND. 

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, American Society of Clinical Oncology, National Comprehensive Cancer Network, the PCPI and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications. 

CPT(R) contained in the Measure specifications is copyright 2004-2012 American Medical Association. LOINC(R) copyright 2004-2012 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2012 International Health Terminology Standards Development Organisation. ICD-10 copyright 2012 World Health Organization. All Rights Reserved.

Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>The receipt of adjuvant chemotherapy in AJCC Stage III colon cancer patients following primary surgical treatment is associated with a significant survival benefit.</rationale><recommendations>For stage III patients (T1-4, N1-2, M0), the panel recommends 6 months of adjuvant chemotherapy following primary surgical treatment. The treatment options are: 5-FU/LV/oxaliplatin (mFOLFOX6) as the standard of care (category 1); bolus 5-FU/LV/oxaliplatin (FLOX, category 1); capecitabine/oxaliplatin (CapeOx); or single agent capecitabine (category 2A) or 5-FU/LV (category 2A) in patients felt to be inappropriate for oxaliplatin therapy. (NCCN, 2012) 

There is currently a shortage of leucovorin in the United States. There are no specific data to guide management under these circumstances, and all proposed strategies are empiric. The panel recommends several possible options to help alleviate the problems associated with this shortage. One is the use of levo-leucovorin, which is commonly used in Europe. A dose of 200 mg/m2 of levo?leucovorin is equivalent to 400 mg/m2 of standard leucovorin. Another option is for practices or institutions to use lower doses of leucovorin for all doses in all patients, since the panel feels that lower doses are likely to be as efficacious as higher doses, based on several studies. Finally, if none of the above options are available, treatment without leucovorin would be reasonable. (NCCN)</recommendations><improvementNotations>Higher score indicates better quality</improvementNotations><references><reference>National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Colon Cancer. Version 2, 2012. Available at: http://www.nccn.org.</reference></references><definitions>Adjuvant Chemotherapy ? According to current NCCN guidelines, the following therapies are recommended: 5-FU/LV/oxaliplatin (mFOLFOX6) as the standard of care (category 1); bolus 5-FU/LV/oxaliplatin (FLOX, category 1); capecitabine/oxaliplatin (CapeOx, category 1); or single agent capecitabine (category 2A) or 5-FU/LV (category 2A) in patients felt to be inappropriate for oxaliplatin therapy (NCCN). See clinical recommendation statement for cases where leucovorin is not available.
Prescribed ? May include prescription ordered for the patient for adjuvant chemotherapy at one or more visits in the 12-month period OR patient already receiving adjuvant chemotherapy as documented in the current medication list.</definitions><guidance>The measure logic includes the combination of 5-FU/LV/oxaliplatin which will capture either mFOLFOX6 or FLOX, category 1, as referenced in the definitions section.  
The denominator for this measure has been limited to patients with a first recorded colon cancer diagnosis during the 12 month reporting period. The numerator captures patients who are prescribed adjuvant chemotherapy or received adjuvant chemotherapy during the 12 month period. "Referred for Chemotherapy" is not separately specified, as this option can be captured either through the "Medication Order: Chemotherapy for Colon Cancer" numerator option or the patient reason exception: "Medication, Administered not done: Patient reason" for "Chemotherapy for Colon Cancer". Additional valid medical reason exceptions might include acute renal insufficiency, neutropenia, or leukopenia. Date of diagnosis is defined as the date of pathologic diagnosis.</guidance><transmissionFormat>TBD</transmissionFormat><initialPatientPopDescription>All patients aged 18 through 80 years with colon cancer</initialPatientPopDescription><denominatorDescription>Equals Initial Patient Population with AJCC Stage III colon cancer</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Patients who are referred for chemotherapy, prescribed chemotherapy, or who have previously received adjuvant chemotherapy within the 12 month reporting period</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Documentation of medical reason(s) for not referring for or prescribing adjuvant chemotherapy (eg, medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient?s cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons)
Documentation of patient reason(s) for not referring for or prescribing adjuvant chemotherapy (eg, patient refusal, other patient reasons)
Documentation of system reason(s) for not referring for or prescribing adjuvant chemotherapy (eg, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="860c422a-e38c-47b2-982d-cdb6275b4da2">None</qualityMeasureSet>
<finalizedDate value="201404161652-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3d61-56a7-013e-6b81e70055ac" name="ONC Administrative Sex"/><elementRef id="40280381-3d61-56a7-013e-6b81e70055ad" name="Race"/><elementRef id="40280381-3d61-56a7-013e-6b81e70055ae" name="Ethnicity"/><elementRef id="40280381-3d61-56a7-013e-6b81e70055af" name="Payer"/></supplementalDataElements><measureGrouping><group sequence="1"><clause displayName="Initial Patient Population 1" type="initialPatientPopulation" uuid="4F5C92A2-37D1-4D6A-B816-0494A4594244"><logicalOp displayName="AND" type="and"><relationalOp displayName="&gt;= 18 years Starts Before Start Of" operatorType="Greater Than or Equal To" quantity="18" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3d61-56a7-013e-6b81e70055b0" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" type="qdm"/></relationalOp><relationalOp displayName="&lt; 80 years Starts Before Start Of" operatorType="Less Than" quantity="80" type="SBS" unit="years"><elementRef displayName="birth date : Patient Characteristic Birthdate" id="40280381-3d61-56a7-013e-6b81e70055b0" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" type="qdm"/></relationalOp><functionalOp displayName="COUNT &gt;= 2  " operatorType="Greater Than or Equal To" quantity="2" type="COUNT" unit=" " uuid="5be09167-a8a5-4b29-aef9-3c016a3d7897"><relationalOp displayName="During" type="DURING"><logicalOp displayName="OR" type="or"><elementRef displayName="Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b3" type="qdm"/><elementRef displayName="Patient Provider Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b5" type="qdm"/></logicalOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" type="qdm"/></relationalOp></functionalOp><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" type="qdm"/></relationalOp></relationalOp><functionalOp displayName="NOT" type="NOT" uuid="6a7d9801-3cc9-4dc5-af6b-69eebe1d347a"><relationalOp displayName="Ends Before Start Of" type="EBS"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/></relationalOp></functionalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/><relationalOp displayName="During" type="DURING"><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" type="qdm"/></relationalOp></relationalOp><functionalOp displayName="NOT" type="NOT" uuid="57bec099-95f6-421e-a3a2-f8bf315e5a54"><relationalOp displayName="Ends Before Start Of" type="EBS"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></relationalOp></functionalOp></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" type="qdm"/></relationalOp><functionalOp displayName="FIRST" type="FIRST" uuid="a559e0d1-7702-47c6-ab04-d2a5ff06a7e7"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/></functionalOp></logicalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="B051BB8E-EE14-42FE-91A7-29E8C6ED6D54"><logicalOp displayName="AND" type="and"><functionalOp displayName="NOT" type="NOT" uuid="6beab89c-3acd-4e6b-a502-59d525062804"><relationalOp displayName="Starts Before Start Of" type="SBS"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/></relationalOp></functionalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70255e8"/></elementRef><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155b9"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155ba"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155bb"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155bc"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155bd"/></elementRef></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155be"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155bf"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155c0"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155c1"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155c3"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155c4"/></elementRef></logicalOp></logicalOp><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155bd"/></elementRef><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"><attribute mode="Value Set" name="result" qdmUUID="40280381-3d61-56a7-013e-6b81e70155c2"/></elementRef></logicalOp></logicalOp></logicalOp></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="81A3A477-A97E-4ED5-AEC7-19CF966F6E37"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><relationalOp displayName="&lt;= 120 days Starts Before Or During" operatorType="Less Than or Equal To" quantity="120" type="SBOD" unit="days"><elementRef displayName="Occurrence A of Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" type="qdm"/><elementRef displayName="Measurement End Date : Timing Element" id="40280381-3d61-56a7-013e-6b81e70255da" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cd" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cd" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cd" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ce" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ce" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ce" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine : Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255e3" type="qdm"/><elementRef displayName="Chemotherapy for Colon Cancer - capecitabine allergen : Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055a8" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c6" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c6" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c6" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155c5" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155c5" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155c5" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil : Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255dd" type="qdm"/><elementRef displayName="Chemotherapy for Colon Cancer - fluorouracil allergen : Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055a9" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c9" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c9" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c9" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ca" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ca" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ca" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255df" type="qdm"/><elementRef displayName="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin allergen : Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055aa" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cb" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cb" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cb" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155cc" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d7"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155cc" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d8"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155cc" type="qdm"><attribute mode="Value Set" name="negation rationale" qdmUUID="40280381-3d61-56a7-013e-6b81e70255d9"/></elementRef><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin : Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255e1" type="qdm"/><elementRef displayName="Chemotherapy for Colon Cancer - oxaliplatin allergen : Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055ab" type="qdm"/></logicalOp></logicalOp><elementRef displayName="Metastatic Sites Common to Colon Cancer : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70255db" type="qdm"/><elementRef displayName="Allergy to Antineoplastic Therapy : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70255e4" type="qdm"/><elementRef displayName="Intolerance to Antineoplastic Therapy : Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70255e5" type="qdm"/><elementRef displayName="ECOG Performance Status-Poor : Patient Characteristic" id="40280381-3d61-56a7-013e-6b81e70255e6" type="qdm"/><elementRef displayName="Clinical Trial Participant : Patient Characteristic Clinical Trial Participant" id="40280381-3d61-56a7-013e-6b81e70255e7" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="37BDE5AC-E483-4651-9648-E4EE350D5B0C"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cf" type="qdm"/><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cf" type="qdm"/><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155d0" type="qdm"/><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155d0" type="qdm"/><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155d1" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d3" type="qdm"/></logicalOp><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155d1" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d3" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d2" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d4" type="qdm"/></logicalOp><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d2" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d4" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155d0" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d6" type="qdm"/></logicalOp><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155d0" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d6" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cf" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d5" type="qdm"/></logicalOp><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - capecitabine : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cf" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d5" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155d1" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d3" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d5" type="qdm"/></logicalOp><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155d1" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d3" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d5" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp><logicalOp displayName="AND" type="and"><relationalOp displayName="Starts After Start Of" type="SAS"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d2" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d4" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d6" type="qdm"/></logicalOp><elementRef displayName="Occurrence A of Clinical Staging Procedure : Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" type="qdm"/></relationalOp><relationalOp displayName="Starts Before Or During" type="SBOD"><logicalOp displayName="AND" type="and"><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - fluorouracil : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d2" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d4" type="qdm"/><elementRef displayName="Occurrence A of Chemotherapy for Colon Cancer - oxaliplatin : Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d6" type="qdm"/></logicalOp><logicalOp displayName="OR" type="or"><elementRef displayName="Occurrence A of Office Visit : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" type="qdm"/><elementRef displayName="Occurrence A of Face-to-Face Interaction : Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" type="qdm"/></logicalOp></relationalOp></logicalOp></logicalOp></logicalOp></clause></group></measureGrouping><elementLookUp><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Procedure, Result" id="40280381-3d61-56a7-013e-6b81e70055a7" instance="Occurrence A" name="Clinical Staging Procedure" oid="2.16.840.1.113883.3.526.3.1098" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055a7" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055a8" name="Chemotherapy for Colon Cancer - capecitabine allergen" oid="2.16.840.1.113883.3.526.3.1485" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055a8" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055a9" name="Chemotherapy for Colon Cancer - fluorouracil allergen" oid="2.16.840.1.113883.3.526.3.1486" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055a9" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055aa" name="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin allergen" oid="2.16.840.1.113883.3.526.3.1490" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055aa" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Allergy" id="40280381-3d61-56a7-013e-6b81e70055ab" name="Chemotherapy for Colon Cancer - oxaliplatin allergen" oid="2.16.840.1.113883.3.526.3.1495" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055ab" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3d61-56a7-013e-6b81e70055ac" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="Administrative Sex" uuid="40280381-3d61-56a7-013e-6b81e70055ac" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3d61-56a7-013e-6b81e70055ad" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013e-6b81e70055ad" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3d61-56a7-013e-6b81e70055ae" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDC" uuid="40280381-3d61-56a7-013e-6b81e70055ae" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3d61-56a7-013e-6b81e70055af" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="Source of Payment Typology" uuid="40280381-3d61-56a7-013e-6b81e70055af" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Patient Characteristic Birthdate" id="40280381-3d61-56a7-013e-6b81e70055b0" name="birth date" oid="2.16.840.1.113883.3.560.100.4" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3d61-56a7-013e-6b81e70055b0" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-6b81e70055b1" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-6b81e70055b1" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70055b2" instance="Occurrence A" name="Colon Cancer" oid="2.16.840.1.113883.3.526.3.391" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055b2" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b3" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055b3" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b4" instance="Occurrence A" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055b4" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70055b5" name="Patient Provider Interaction" oid="2.16.840.1.113883.3.526.3.1012" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70055b5" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155b9" name="Colon Cancer Primary Tumor Size T1" oid="2.16.840.1.113883.3.526.3.1292" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155b9" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155ba" name="Colon Cancer Primary Tumor Size T2" oid="2.16.840.1.113883.3.526.3.1293" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155ba" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155bb" name="Colon Cancer Primary Tumor Size T3" oid="2.16.840.1.113883.3.526.3.1294" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155bb" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155bc" name="Colon Cancer Primary Tumor Size T4a" oid="2.16.840.1.113883.3.526.3.1295" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155bc" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155bd" name="Colon Cancer Primary Tumor Size T4b" oid="2.16.840.1.113883.3.526.3.1296" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155bd" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155be" name="Colon Cancer Regional Lymph Node Status N1" oid="2.16.840.1.113883.3.526.3.1297" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155be" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155bf" name="Colon Cancer Regional Lymph Node Status N1a" oid="2.16.840.1.113883.3.526.3.1327" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155bf" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155c0" name="Colon Cancer Regional Lymph Node Status N1b" oid="2.16.840.1.113883.3.526.3.1328" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c0" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155c1" name="Colon Cancer Regional Lymph Node Status N1c" oid="2.16.840.1.113883.3.526.3.1298" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c1" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155c2" name="Colon Cancer Regional Lymph Node Status N2" oid="2.16.840.1.113883.3.526.3.1299" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c2" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155c3" name="Colon Cancer Regional Lymph Node Status N2a" oid="2.16.840.1.113883.3.526.3.1300" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c3" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70155c4" name="Colon Cancer Regional Lymph Node Status N2b" oid="2.16.840.1.113883.3.526.3.1301" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c4" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155c5" name="Chemotherapy for Colon Cancer - fluorouracil" oid="2.16.840.1.113883.3.526.3.1289" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c5" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c6" name="Chemotherapy for Colon Cancer - fluorouracil" oid="2.16.840.1.113883.3.526.3.1289" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c6" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Encounter, Performed" id="40280381-3d61-56a7-013e-6b81e70155c7" instance="Occurrence A" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c7" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155c9" name="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin" oid="2.16.840.1.113883.3.526.3.1290" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155c9" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ca" name="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin" oid="2.16.840.1.113883.3.526.3.1290" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155ca" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cb" name="Chemotherapy for Colon Cancer - oxaliplatin" oid="2.16.840.1.113883.3.526.3.1291" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155cb" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155cc" name="Chemotherapy for Colon Cancer - oxaliplatin" oid="2.16.840.1.113883.3.526.3.1291" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155cc" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cd" name="Chemotherapy for Colon Cancer - capecitabine" oid="2.16.840.1.113883.3.526.3.1288" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155cd" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155ce" name="Chemotherapy for Colon Cancer - capecitabine" oid="2.16.840.1.113883.3.526.3.1288" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155ce" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155cf" instance="Occurrence A" name="Chemotherapy for Colon Cancer - capecitabine" oid="2.16.840.1.113883.3.526.3.1288" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155cf" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70155d0" instance="Occurrence A" name="Chemotherapy for Colon Cancer - capecitabine" oid="2.16.840.1.113883.3.526.3.1288" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155d0" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70155d1" instance="Occurrence A" name="Chemotherapy for Colon Cancer - fluorouracil" oid="2.16.840.1.113883.3.526.3.1289" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70155d1" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d2" instance="Occurrence A" name="Chemotherapy for Colon Cancer - fluorouracil" oid="2.16.840.1.113883.3.526.3.1289" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d2" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d3" instance="Occurrence A" name="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin" oid="2.16.840.1.113883.3.526.3.1290" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d3" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d4" instance="Occurrence A" name="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin" oid="2.16.840.1.113883.3.526.3.1290" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d4" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Administered" id="40280381-3d61-56a7-013e-6b81e70255d5" instance="Occurrence A" name="Chemotherapy for Colon Cancer - oxaliplatin" oid="2.16.840.1.113883.3.526.3.1291" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d5" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Order" id="40280381-3d61-56a7-013e-6b81e70255d6" instance="Occurrence A" name="Chemotherapy for Colon Cancer - oxaliplatin" oid="2.16.840.1.113883.3.526.3.1291" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d6" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70255d7" name="Medical Reason" oid="2.16.840.1.113883.3.526.3.1007" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d7" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70255d8" name="Patient Reason" oid="2.16.840.1.113883.3.526.3.1008" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d8" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70255d9" name="System Reason" oid="2.16.840.1.113883.3.526.3.1009" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255d9" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3d61-56a7-013e-6b81e70255da" name="Measurement End Date" oid="2.16.840.1.113883.3.67.1.101.1.55" suppDataElement="false" taxonomy="NQF" uuid="40280381-3d61-56a7-013e-6b81e70255da" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70255db" name="Metastatic Sites Common to Colon Cancer" oid="2.16.840.1.113883.3.526.3.490" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255db" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255dd" name="Chemotherapy for Colon Cancer - fluorouracil" oid="2.16.840.1.113883.3.526.3.1289" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255dd" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255df" name="Chemotherapy for Colon Cancer - leucovorin and levo-leucovorin" oid="2.16.840.1.113883.3.526.3.1290" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255df" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255e1" name="Chemotherapy for Colon Cancer - oxaliplatin" oid="2.16.840.1.113883.3.526.3.1291" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e1" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Medication, Intolerance" id="40280381-3d61-56a7-013e-6b81e70255e3" name="Chemotherapy for Colon Cancer - capecitabine" oid="2.16.840.1.113883.3.526.3.1288" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e3" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70255e4" name="Allergy to Antineoplastic Therapy" oid="2.16.840.1.113883.3.526.3.1280" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e4" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Diagnosis, Active" id="40280381-3d61-56a7-013e-6b81e70255e5" name="Intolerance to Antineoplastic Therapy" oid="2.16.840.1.113883.3.526.3.1287" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e5" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Patient Characteristic" id="40280381-3d61-56a7-013e-6b81e70255e6" name="ECOG Performance Status-Poor" oid="2.16.840.1.113883.3.526.3.1279" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e6" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="Patient Characteristic Clinical Trial Participant" id="40280381-3d61-56a7-013e-6b81e70255e7" name="Clinical Trial Participant" oid="2.16.840.1.113883.3.526.3.1125" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e7" version="1"/><qdm codeSystemName="American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)" datatype="attribute" id="40280381-3d61-56a7-013e-6b81e70255e8" name="Colon Distant Metastasis Status M0" oid="2.16.840.1.113883.3.526.3.1337" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3d61-56a7-013e-6b81e70255e8" version="1"/></elementLookUp><strata displayName="Stratification"><clause displayName="Stratum 1" type="stratum" uuid="40280381-3d61-56a7-013e-6b82bc9356af"><logicalOp displayName="AND" type="and"/></clause></strata></measure>
